investordatabase.org

Epidarex Capital

epidarex.com Direct investor

Epidarex Capital is a transatlantic venture capital firm that invests in early-stage life science and health technology companies in emerging research hubs in the UK and US. They provide seed and Series A funding, often to university spin-outs, and focus on building companies with transformative science.

Epidarex Capital is a venture capital firm headquartered in Edinburgh, United Kingdom. It invests directly in companies, from seed to Series A, in life science, health technology, biotechnology and pharmaceuticals. 27 portfolio companies, as it reports.

Layer
Direct investor
Type
Venture capital
Stage
SeedSeries A
Headquarters
Edinburgh, United Kingdom
Invests in
US, UK
Sectors
life science, health technology, biotechnology, pharmaceuticals, medical devices, health tech
Portfolio
27 companies

Team, as Epidarex Capital publishes it

  • A. Sinclair Dunlop Managing Partner
  • Kyparissia Sirinakis Founding Partner
  • Elizabeth Roper Ph.D. Managing Partner
  • Peter Finan Ph.D. Managing Partner
  • Mary Canning Ph.D. Partner
  • Lori Krim Gough Ph.D. Partner
  • Henning Steinhagen Ph.D. Venture Partner
  • Anthony Voveris Chief Financial Officer
  • Matthew Miessau Principal
  • Victor Pong Ph.D. Associate
  • Melissa Lezameta Ph.D. Senior Associate
  • Bridget Harris Director of Operations

Names and roles exactly as listed on epidarex.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 22 co-investors found.

and 12 more — the graph.

Where this comes from

Every fact above was read from a page Epidarex Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 935 · added 2026-08-28 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under